Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Thyroid Neoplasms × Metformin × Clear all

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 8 Thyroid Neoplasms 1 Prostatic Neoplasms 1 Obesity 1 Infertility, Female 1 Communicable Diseases 1

Interventions

trametinib 2 anlotinib 2 sintilimab 1 selpercatinib 1 pralsetinib 1 pembrolizumab 1 lenvatinib 1 larotrectinib 1 dabrafenib 1 cabozantinib 1 Vindesine 1 Triiodothyronine 1 Thyroxine 1 TP protocol 1 Surgical Procedures, Operative 1 Paclitaxel 1 Metformin 1 Iodine-131 1 Gemcitabine 1 Doxorubicin 1 Docetaxel 1 Cyclophosphamide 1 Conversion to Open Surgery 1 Cisplatin 1 CP protocol 1 Bariatric Surgery 1 (177)Lu-DOTA-EB-TATE 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05468554 2022-10-19

METHYR

Medical University of Bialystok

Phase 3 Not yet recruiting

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡